X
API Suppliers
US DMFs Filed
CEP/COS Certifications
0
JDMFs Filed
0
Other Certificates
Other Suppliers
0
USA (Orange Book)
Europe
Canada
Australia
0
South Africa
0
Uploaded Dossiers
U.S. Medicaid
Annual Reports
0
0
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215139
https://www.fiercepharma.com/pharma/most-expensive-meds-u-s-topped-by-novartis-and-spark-gene-therapies
https://www.businesswire.com/news/home/20181227005041/en/Horizon-Pharma-plc-Announces-FDA-Approval-Expand
http://www.pharmatimes.com/news/sobi_secures_nhs_reimbursement_for_ravicti_1249938
https://www.businesswire.com/news/home/20180716005166/en/Horizon-Pharma-plc-Announces-U.S.-Patent-Trademark
http://ir.horizon-pharma.com/news-releases/news-release-details/horizon-pharma-plc-announces-us-patent-and-trademark-office-24
http://www.fiercepharma.com/pharma/biomarin-picks-up-fda-approval-for-orphan-drug-brineura
http://www.prnewswire.com/news-releases/sobi-and-horizon-pharma-enter-five-year-distribution-agreement-for-ravicti-and-ammonaps-outside-the-united-states-300374421.html
https://www.thestreet.com/story/13727391/1/more-rare-disease-dealmaking-to-follow-horizon-s-raptor-deal.html
https://www.pharmacompass.com/pdf/news/horizon-theraps-ravicti-glycerol-phenylbutyrate-approved-in-us-1474376685.pdf
https://pulmonaryhypertensionnews.com/2016/06/27/2016FDA-approved-4-PBA-protects-against-pulmonary-arterial-hypertension-in-rats/
http://www.marketwired.com/press-release/horizon-pharma-plc-receives-health-canada-approval-ravictir-glycerol-phenylbutyrate-nasdaq-hznp-2107509.htm
http://www.bloomberg.com/news/articles/2015-03-30/horizon-to-buy-hyperion-for-1-1-billion-gain-rare-disease-drug
Market Place
Share 
